Cellular Starting Materials Market Size, Share & Trends Analysis Report By Product (Leukopaks, Cells & Tissues), By Grade (GMP, Research-use), By End U-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Cellular Starting Materials Market Growth & Trends
The global cellular starting materials market size is anticipated t%li%reach USD 4.84 billion by 2030, growingand is anticipated t%li%expand at a CAGR of 22.74% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, rising investments, growing demand for cell and gene-based therapies, and technological innovations are expected t%li%enhance the cellular starting materials market over the forecast period.
Cellular starting materials play a crucial role in supporting the development of cell and gene therapies. They are essential for both autologous and allogeneic cell therapies. As the field of cell therapy continues t%li%expand rapidly, the demand for high-quality human cellular starting material is increasingincreases. Cell-based treatments are being investigated for a variety of conditions, including oncology, neurodegenerative disorders, and autoimmune diseases, leading t%li%increased demand for different types of starting materials. Moreover, ongoing advancements in bioprocessing technologies, cell culture techniques, and quality control measures have enhanced the efficiency and scalability of manufacturing cellular starting materials, enabling companies t%li%meet the increasing demand for these materials while maintaining product quality and consistency.
The COVID-19 pandemic had a significant impact onsignificantly impacted the market, with disruptions in supply chains and manufacturing processes leading t%li%shortages and delays in manufacturing timelines. In the case of autologous cell therapies, the pandemic has caused extended patient collection times as patient-derived cells are used as starting material. However, the pandemic als%li%underscored the importance of cell-based therapies and led t%li%increased investments in the sector and accelerated regulatory approvals for some treatments.
However, strict regulations related t%li%cell therapies present a major challenge t%li%the cellular starting materials market. These regulations increase the costs of manufacturing cell and gene therapy products and obtaining the starting material. Various regions around the worldworldwide have established specific regulations governing the collection, processing, and use of cellular starting material for cell therapies. Cellular therapy products meeting specific criteria outlined in 21 CFR 1271.10(a) are regulated solely as Human Cells, Tissues, and Cellular and & Tissue-Based Products (HCT/Ps) under Section 361 of the Public Health Service Act of the U.S.
Cellular Starting Materials Market Report Highlights
Cellular Starting Materials Market Growth & Trends
The global cellular starting materials market size is anticipated t%li%reach USD 4.84 billion by 2030, growingand is anticipated t%li%expand at a CAGR of 22.74% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, rising investments, growing demand for cell and gene-based therapies, and technological innovations are expected t%li%enhance the cellular starting materials market over the forecast period.
Cellular starting materials play a crucial role in supporting the development of cell and gene therapies. They are essential for both autologous and allogeneic cell therapies. As the field of cell therapy continues t%li%expand rapidly, the demand for high-quality human cellular starting material is increasingincreases. Cell-based treatments are being investigated for a variety of conditions, including oncology, neurodegenerative disorders, and autoimmune diseases, leading t%li%increased demand for different types of starting materials. Moreover, ongoing advancements in bioprocessing technologies, cell culture techniques, and quality control measures have enhanced the efficiency and scalability of manufacturing cellular starting materials, enabling companies t%li%meet the increasing demand for these materials while maintaining product quality and consistency.
The COVID-19 pandemic had a significant impact onsignificantly impacted the market, with disruptions in supply chains and manufacturing processes leading t%li%shortages and delays in manufacturing timelines. In the case of autologous cell therapies, the pandemic has caused extended patient collection times as patient-derived cells are used as starting material. However, the pandemic als%li%underscored the importance of cell-based therapies and led t%li%increased investments in the sector and accelerated regulatory approvals for some treatments.
However, strict regulations related t%li%cell therapies present a major challenge t%li%the cellular starting materials market. These regulations increase the costs of manufacturing cell and gene therapy products and obtaining the starting material. Various regions around the worldworldwide have established specific regulations governing the collection, processing, and use of cellular starting material for cell therapies. Cellular therapy products meeting specific criteria outlined in 21 CFR 1271.10(a) are regulated solely as Human Cells, Tissues, and Cellular and & Tissue-Based Products (HCT/Ps) under Section 361 of the Public Health Service Act of the U.S.
Cellular Starting Materials Market Report Highlights
- Leukopaks dominated the product segment with a market share of 70.80% in 2023, as they are essential cellular starting materials for cell-based therapies.
- In 2023, GMP dominated the grade segment and held the largest market share in terms of revenue and is expected t%li%grow at the highest CAGR of 22.78% over the forecast period.
- Pharmaceutical and biotechnology companies dominated the end-use market with the largest share of 51.04% in 2023, driven by their significant investment in research and development t%li%bring novel treatments t%li%market, leveraging cellular starting materials as key components in their manufacturing processes.
- Based on end use, tThe CMOs & CROs segment is anticipated t%li%grow at the fastest CAGR due t%li%their increasing adoption and investment in advanced research and manufacturing technologies.
- The North American region dominated the cellular starting materials market with a share of 43.49% owing t%li%factors such as increasing investments in R&D activities, rising demand for cell-based therapies, and advanced healthcare infrastructure.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Grade Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. CELLULAR STARTING MATERIALS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for cell therapies
3.2.1.2. Advancements in research and development for cell-based therapies
3.2.1.3. Technological innovation
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials for cell therapies
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Cellular Starting Materials Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. CELLULAR STARTING MATERIALS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Cellular Starting Materials Market Product Movement Analysis
4.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
4.4. Leukopaks
4.4.1. Leukopaks market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Cells & Tissues
4.5.1. Cells & tissues market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. CELLULAR STARTING MATERIALS MARKET: GRADE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Cellular Starting Materials Market Grade Movement Analysis
5.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Grade, 2018 - 2030 (USD Million)
5.4. GMP
5.4.1. GMP market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Research-use
5.5.1. Research-use market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. CELLULAR STARTING MATERIALS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Cellular Starting Materials Market End Use Movement Analysis
6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
6.5. CMOs & CROs
6.5.1. CMOs & CROs market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. CELLULAR STARTING MATERIALS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030 (2018 - 2030)
7.4. North America
7.4.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Target disease prevalence
7.4.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Target disease prevalence
7.4.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. Target disease prevalence
7.4.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Target disease prevalence
7.5.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. UK
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Target disease prevalence
7.5.3.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Target disease prevalence
7.5.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Target disease prevalence
7.5.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Target disease prevalence
7.5.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Target disease prevalence
7.5.7.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory framework
7.5.8.4. Target disease prevalence
7.5.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Regulatory framework
7.5.9.4. Target disease prevalence
7.5.9.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Target disease prevalence
7.6.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Target disease prevalence
7.6.3.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Target disease prevalence
7.6.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Target disease prevalence
7.6.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Target disease prevalence
7.6.6.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Target disease prevalence
7.6.7.4. Regulatory framework
7.6.7.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Target disease prevalence
7.7.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Target disease prevalence
7.7.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Target disease prevalence
7.8.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Target disease prevalence
7.8.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Target disease prevalence
7.8.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Target disease prevalence
7.8.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. AllCells
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Charles River Laboratories
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. BioIVT
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. NMDP BioTherapies
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. CGT GLOBAL
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Excellos
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Anthony Nolan
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. STEMCELL Technologies
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. HumanCells Bio
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. AcceGen
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Grade Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. CELLULAR STARTING MATERIALS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for cell therapies
3.2.1.2. Advancements in research and development for cell-based therapies
3.2.1.3. Technological innovation
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials for cell therapies
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Cellular Starting Materials Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. CELLULAR STARTING MATERIALS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Cellular Starting Materials Market Product Movement Analysis
4.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
4.4. Leukopaks
4.4.1. Leukopaks market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Cells & Tissues
4.5.1. Cells & tissues market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. CELLULAR STARTING MATERIALS MARKET: GRADE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Cellular Starting Materials Market Grade Movement Analysis
5.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Grade, 2018 - 2030 (USD Million)
5.4. GMP
5.4.1. GMP market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Research-use
5.5.1. Research-use market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. CELLULAR STARTING MATERIALS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Cellular Starting Materials Market End Use Movement Analysis
6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
6.5. CMOs & CROs
6.5.1. CMOs & CROs market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. CELLULAR STARTING MATERIALS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030 (2018 - 2030)
7.4. North America
7.4.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Target disease prevalence
7.4.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Target disease prevalence
7.4.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. Target disease prevalence
7.4.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Target disease prevalence
7.5.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. UK
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Target disease prevalence
7.5.3.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Target disease prevalence
7.5.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Target disease prevalence
7.5.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Target disease prevalence
7.5.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Target disease prevalence
7.5.7.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory framework
7.5.8.4. Target disease prevalence
7.5.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Regulatory framework
7.5.9.4. Target disease prevalence
7.5.9.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Target disease prevalence
7.6.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Target disease prevalence
7.6.3.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Target disease prevalence
7.6.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Target disease prevalence
7.6.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Target disease prevalence
7.6.6.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Target disease prevalence
7.6.7.4. Regulatory framework
7.6.7.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Target disease prevalence
7.7.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Target disease prevalence
7.7.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Target disease prevalence
7.8.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Target disease prevalence
7.8.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Target disease prevalence
7.8.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Target disease prevalence
7.8.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. AllCells
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Charles River Laboratories
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. BioIVT
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. NMDP BioTherapies
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. CGT GLOBAL
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Excellos
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Anthony Nolan
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. STEMCELL Technologies
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. HumanCells Bio
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. AcceGen
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global cellular starting materials market, by region, 2018 - 2030 (USD Million)
Table 3 Global cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 4 Global cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 5 Global cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 6 North America cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 7 North America cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 8 North America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 9 North America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 12 U.S. cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 14 Canada cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 15 Canada cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 18 Mexico cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 20 Europe cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 21 Europe cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 22 Europe cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 24 Germany cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 25 Germany cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 26 UK cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 27 UK cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 28 UK cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 29 France cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 30 France cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 31 France cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 33 Italy cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 34 Italy cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 36 Spain cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 37 Spain cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 40 Denmark cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 43 Sweden cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 45 Norway cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 46 Norway cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 50 Asia Pacific cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 51 China cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 52 China cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 53 China cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 55 Japan cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 56 Japan cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 57 India cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 58 India cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 59 India cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 62 South Korea cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 64 Australia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 65 Australia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 68 Thailand cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 71 Latin America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 72 Latin America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 75 Brazil cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 78 Argentina cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 80 MEA cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 81 MEA cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 82 MEA cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 85 South Africa cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 90 UAE cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 91 UAE cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 94 Kuwait cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global cellular starting materials market, by region, 2018 - 2030 (USD Million)
Table 3 Global cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 4 Global cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 5 Global cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 6 North America cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 7 North America cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 8 North America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 9 North America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 12 U.S. cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 14 Canada cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 15 Canada cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 18 Mexico cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 20 Europe cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 21 Europe cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 22 Europe cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 24 Germany cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 25 Germany cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 26 UK cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 27 UK cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 28 UK cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 29 France cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 30 France cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 31 France cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 33 Italy cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 34 Italy cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 36 Spain cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 37 Spain cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 40 Denmark cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 43 Sweden cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 44 Norway cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 45 Norway cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 46 Norway cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 50 Asia Pacific cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 51 China cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 52 China cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 53 China cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 55 Japan cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 56 Japan cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 57 India cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 58 India cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 59 India cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 62 South Korea cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 64 Australia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 65 Australia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 68 Thailand cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 71 Latin America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 72 Latin America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 75 Brazil cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 78 Argentina cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA cellular starting materials market, by country, 2018 - 2030 (USD Million)
Table 80 MEA cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 81 MEA cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 82 MEA cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 85 South Africa cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 90 UAE cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 91 UAE cellular starting materials market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait cellular starting materials market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait cellular starting materials market, by grade, 2018 - 2030 (USD Million)
Table 94 Kuwait cellular starting materials market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Veterinary molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for a commodity flow analysis of veterinary molecular diagnostics market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market value, 2023 (USD Billion)
Fig. 17 Ancillary market outlook, 2023
Fig. 18 Veterinary Molecular Diagnostics Market Dynamics
Fig. 19 Estimated animal population, 2018 - 2023 by key species and key countries
Fig. 20 Veterinary Molecular Diagnostics Market: PORTER’s analysis
Fig. 21 Veterinary Molecular Diagnostics Market: PESTEL analysis
Fig. 22 Veterinary Molecular Diagnostics Market by Product: Key Takeaways
Fig. 23 Veterinary Molecular Diagnostics Market by Product, 2023 & 2030
Fig. 24 Instruments market, 2018 - 2030 (USD Million)
Fig. 25 Test Kits & Reagents market, 2018 - 2030 (USD Million)
Fig. 26 Software & Services market, 2018 - 2030 (USD Million)
Fig. 27 Veterinary Molecular Diagnostics Market by Animal Type: Key Takeaways
Fig. 28 Veterinary Molecular Diagnostics Market by Animal Type, 2023 & 2030
Fig. 29 Companion Animal market, 2018 - 2030 (USD Million)
Fig. 30 Dogs market, 2018 - 2030 (USD Million)
Fig. 31 Cats market, 2018 - 2030 (USD Million)
Fig. 32 Horses market, 2018 - 2030 (USD Million)
Fig. 33 Other companion animals market, 2018 - 2030 (USD Million)
Fig. 34 Production Animal market, 2018 - 2030 (USD Million)
Fig. 35 Cattle market, 2018 - 2030 (USD Million)
Fig. 36 Poultry market, 2018 - 2030 (USD Million)
Fig. 37 Swine market, 2018 - 2030 (USD Million)
Fig. 38 Other production animals market, 2018 - 2030 (USD Million)
Fig. 39 Veterinary Molecular Diagnostics Market by Technology: Key Takeaways
Fig. 40 Veterinary Molecular Diagnostics Market by Technology, Market Share, 2023 & 2030
Fig. 41 PCR market, 2018 - 2030 (USD Million)
Fig. 42 DNA Sequencing market, 2018 - 2030 (USD Million)
Fig. 43 Microarrays market, 2018 - 2030 (USD Million)
Fig. 44 INAAT kits market, 2018 - 2030 (USD Million)
Fig. 45 Veterinary Molecular Diagnostics Market by Application: Key Takeaways
Fig. 46 Veterinary Molecular Diagnostics Market by Application, Market Share, 2023 & 2030
Fig. 47 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 48 Metabolic disease market, 2018 - 2030 (USD Million)
Fig. 49 Genetics market, 2018 - 2030 (USD Million)
Fig. 50 Other application market, 2018 - 2030 (USD Million)
Fig. 51 Veterinary Molecular Diagnostics Market by End Use: Key Takeaways
Fig. 52 Veterinary Molecular Diagnostics Market by End Use, Market Share, 2023 & 2030
Fig. 53 Veterinary Hospitals & Clinics Market, 2018 - 2030 (USD Million)
Fig. 54 Diagnostic Laboratories market, 2018 - 2030 (USD Million)
Fig. 55 Other End Use market, 2018 - 2030 (USD Million)
Fig. 56 Veterinary Molecular Diagnostics Market revenue, by region, 2023 & 2030 (USD Million)
Fig. 57 Regional market share analysis, 2023 & 2030
Fig. 58 Regional marketplace: Key takeaways
Fig. 59 Regional marketplace: Key takeaways
Fig. 60 Regional marketplace: Key takeaways
Fig. 61 North America Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 U.S. Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Canada Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Mexico Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Europe Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 UK Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Germany Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 France Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Italy Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Spain Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Denmark Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Sweden Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Norway Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Asia Pacific Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 China Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Japan Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 India Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Australia Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Korea Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Thailand Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 99 Latin America Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Brazil Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Argentina Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 MEA Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 South Africa Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Saudi Arabia Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 UAE Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Kuwait Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 113 Market Participant Categorization
Fig. 114 Heat map analysis
Fig. 115 Strategic Framework
Fig. 1 Veterinary molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for a commodity flow analysis of veterinary molecular diagnostics market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market value, 2023 (USD Billion)
Fig. 17 Ancillary market outlook, 2023
Fig. 18 Veterinary Molecular Diagnostics Market Dynamics
Fig. 19 Estimated animal population, 2018 - 2023 by key species and key countries
Fig. 20 Veterinary Molecular Diagnostics Market: PORTER’s analysis
Fig. 21 Veterinary Molecular Diagnostics Market: PESTEL analysis
Fig. 22 Veterinary Molecular Diagnostics Market by Product: Key Takeaways
Fig. 23 Veterinary Molecular Diagnostics Market by Product, 2023 & 2030
Fig. 24 Instruments market, 2018 - 2030 (USD Million)
Fig. 25 Test Kits & Reagents market, 2018 - 2030 (USD Million)
Fig. 26 Software & Services market, 2018 - 2030 (USD Million)
Fig. 27 Veterinary Molecular Diagnostics Market by Animal Type: Key Takeaways
Fig. 28 Veterinary Molecular Diagnostics Market by Animal Type, 2023 & 2030
Fig. 29 Companion Animal market, 2018 - 2030 (USD Million)
Fig. 30 Dogs market, 2018 - 2030 (USD Million)
Fig. 31 Cats market, 2018 - 2030 (USD Million)
Fig. 32 Horses market, 2018 - 2030 (USD Million)
Fig. 33 Other companion animals market, 2018 - 2030 (USD Million)
Fig. 34 Production Animal market, 2018 - 2030 (USD Million)
Fig. 35 Cattle market, 2018 - 2030 (USD Million)
Fig. 36 Poultry market, 2018 - 2030 (USD Million)
Fig. 37 Swine market, 2018 - 2030 (USD Million)
Fig. 38 Other production animals market, 2018 - 2030 (USD Million)
Fig. 39 Veterinary Molecular Diagnostics Market by Technology: Key Takeaways
Fig. 40 Veterinary Molecular Diagnostics Market by Technology, Market Share, 2023 & 2030
Fig. 41 PCR market, 2018 - 2030 (USD Million)
Fig. 42 DNA Sequencing market, 2018 - 2030 (USD Million)
Fig. 43 Microarrays market, 2018 - 2030 (USD Million)
Fig. 44 INAAT kits market, 2018 - 2030 (USD Million)
Fig. 45 Veterinary Molecular Diagnostics Market by Application: Key Takeaways
Fig. 46 Veterinary Molecular Diagnostics Market by Application, Market Share, 2023 & 2030
Fig. 47 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 48 Metabolic disease market, 2018 - 2030 (USD Million)
Fig. 49 Genetics market, 2018 - 2030 (USD Million)
Fig. 50 Other application market, 2018 - 2030 (USD Million)
Fig. 51 Veterinary Molecular Diagnostics Market by End Use: Key Takeaways
Fig. 52 Veterinary Molecular Diagnostics Market by End Use, Market Share, 2023 & 2030
Fig. 53 Veterinary Hospitals & Clinics Market, 2018 - 2030 (USD Million)
Fig. 54 Diagnostic Laboratories market, 2018 - 2030 (USD Million)
Fig. 55 Other End Use market, 2018 - 2030 (USD Million)
Fig. 56 Veterinary Molecular Diagnostics Market revenue, by region, 2023 & 2030 (USD Million)
Fig. 57 Regional market share analysis, 2023 & 2030
Fig. 58 Regional marketplace: Key takeaways
Fig. 59 Regional marketplace: Key takeaways
Fig. 60 Regional marketplace: Key takeaways
Fig. 61 North America Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 U.S. Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Canada Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Mexico Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Europe Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 UK Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Germany Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 France Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Italy Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Spain Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Denmark Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Sweden Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Norway Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Asia Pacific Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 China Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Japan Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 India Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Australia Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Korea Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Thailand Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 99 Latin America Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Brazil Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Argentina Veterinary Molecular Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 MEA Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 South Africa Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Saudi Arabia Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 UAE Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Kuwait Veterinary Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 113 Market Participant Categorization
Fig. 114 Heat map analysis
Fig. 115 Strategic Framework
